Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Economic burden of multiple sclerosis and the role of managed sare organizations in multiple sclerosis management.
Intravenously infused F3.Olig2 improve memory deficit via restoring demyelination in the aged hippocampus following experimental ischemic stroke.
Breaking boundaries-coagulation and fibrinolysis at the neurovascular interface.
Kynurenic Acid Induces Impairment of Oligodendrocyte Viability: On the Role of Glutamatergic Mechanisms.
Rabies virus-mediated oligodendrocyte labeling reveals a single oligodendrocyte myelinates axons from distinct brain regions.
Focal Injection of Ethidium Bromide as a Simple Model to Study Cognitive Deficit and Its Improvement.
Future placebo-controlled trials of disease modifying therapy in relapsing multiple sclerosis would be unethical: No.
Neural Stem Cell Transplantation and CNS Diseases.
Intensive social cognitive treatment (can do treatment) with participation of support partners in persons with relapsing remitting multiple sclerosis: observation of improved self-efficacy, quality of life, anxiety and depression 1 year later.
Occupational mercury exposure in association with prevalence of multiple sclerosis and tremor among US dentists.
miR-145 and miR20a-5p Potentially Mediate Pleiotropic Effects of Interferon-Beta Through Mitogen-Activated Protein Kinase Signaling Pathway in Multiple Sclerosis Patients.
A Urinary Metabolic Signature for Multiple Sclerosis and Neuromyelitis Optica.
The experience of transitioning from relapsing remitting to secondary progressive multiple sclerosis: views of patients and health professionals.
A multiple sclerosis-like disorder in patients with OPA1 mutations.
Acute idiopathic polyradiculoneuritis concurrent with acquired myasthenia gravis in a West Highland white terrier dog.
Immunotherapy-responsive Allodynia due to Distal Acquired Demyelinating Symmetric (DADS) Neuropathy.
Inhibitors of urokinase type plasminogen activator and cytostatic activity from crude plants extracts.
Multiple sclerosis: Dehydration might contribute to fatigue in MS.
Orthopaedic manifestations and diagnostic clues in children with Guillain-Barré syndrome.
Is There an Increased Risk for Ischemic Stroke in Patients with Multiple Sclerosis, and If So, Should Preventive Treatment Be Considered?
Products
Acorda Therapeutics announces initiation of AMPYRA® proof-of-concept study in patients with post-stroke deficits
Corrigendum.
Thrombin and Protein C Pathway in Peripheral Nerve Schwann Cells.
Protective DNA vaccination against organ-specific autoimmunity is highly specific and discriminates between single amino acid substitutions in the peptide autoantigen.
Pages
« first
‹ previous
…
731
732
733
734
735
736
737
738
739
…
next ›
last »